- Home
- DDS vs CRL Comparison
DDS vs CRL Comparison
Compare DDS & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DDS
- CRL
- Stock Information
- Founded
- DDS 1938
- CRL 1947
- Country
- DDS United States
- CRL United States
- Employees
- DDS N/A
- CRL N/A
- Industry
- DDS Department/Specialty Retail Stores
- CRL Biotechnology: Commercial Physical & Biological Resarch
- Sector
- DDS Consumer Discretionary
- CRL Health Care
- Exchange
- DDS Nasdaq
- CRL Nasdaq
- Market Cap
- DDS 6.3B
- CRL 7.1B
- IPO Year
- DDS N/A
- CRL 2000
- Fundamental
- Price
- DDS $433.00
- CRL $158.83
- Analyst Decision
- DDS Sell
- CRL Hold
- Analyst Count
- DDS 2
- CRL 14
- Target Price
- DDS $310.00
- CRL $186.38
- AVG Volume (30 Days)
- DDS 143.0K
- CRL 825.9K
- Earning Date
- DDS 08-14-2025
- CRL 08-06-2025
- Dividend Yield
- DDS 5.87%
- CRL N/A
- EPS Growth
- DDS N/A
- CRL N/A
- EPS
- DDS 36.07
- CRL N/A
- Revenue
- DDS $6,564,393,000.00
- CRL $4,022,597,000.00
- Revenue This Year
- DDS N/A
- CRL N/A
- Revenue Next Year
- DDS N/A
- CRL $2.49
- P/E Ratio
- DDS $12.28
- CRL N/A
- Revenue Growth
- DDS N/A
- CRL N/A
- 52 Week Low
- DDS $282.24
- CRL $91.86
- 52 Week High
- DDS $510.00
- CRL $254.15
- Technical
- Relative Strength Index (RSI)
- DDS 63.80
- CRL 68.06
- Support Level
- DDS $439.64
- CRL $152.73
- Resistance Level
- DDS $460.56
- CRL $158.72
- Average True Range (ATR)
- DDS 12.30
- CRL 4.57
- MACD
- DDS 2.48
- CRL 0.48
- Stochastic Oscillator
- DDS 70.44
- CRL 84.85
About DDS Dillard's Inc.
Dillard's Inc is an American fashion apparel, cosmetics, and home furnishings retailer. Its stores offer a large variety of merchandise and feature products from both national and exclusive brand sources. The company also operates a general contracting construction company, CDI Contractors. CDI Contractors' business includes constructing and remodelling stores for Dillards. The merchandise selections include exclusive brand merchandise such as Antonio Melani, Gianni Bini, Daniel Cremieux, Roundtree & Yorke, and private-label merchandise, among others. The company operates in two business segments; Retail Operations and Construction. The Retail Operations segment generates maximum revenue for the company.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.